KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Current Assets (2016 - 2025)

Quest Diagnostics' Current Assets history spans 17 years, with the latest figure at $2.4 billion for Q4 2025.

  • For Q4 2025, Current Assets fell 0.59% year-over-year to $2.4 billion; the TTM value through Dec 2025 reached $2.4 billion, down 0.59%, while the annual FY2025 figure was $2.4 billion, 0.59% down from the prior year.
  • Current Assets for Q4 2025 was $2.4 billion at Quest Diagnostics, down from $2.4 billion in the prior quarter.
  • Across five years, Current Assets topped out at $3.0 billion in Q1 2021 and bottomed at $1.7 billion in Q2 2023.
  • The 5-year median for Current Assets is $2.4 billion (2022), against an average of $2.3 billion.
  • The largest annual shift saw Current Assets skyrocketed 92.24% in 2021 before it tumbled 30.76% in 2022.
  • A 5-year view of Current Assets shows it stood at $2.7 billion in 2021, then tumbled by 30.76% to $1.9 billion in 2022, then grew by 24.97% to $2.4 billion in 2023, then grew by 0.84% to $2.4 billion in 2024, then dropped by 0.59% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Current Assets are $2.4 billion (Q4 2025), $2.4 billion (Q3 2025), and $2.2 billion (Q2 2025).